Roche, Kyowa Hakko Kogyo Co. Ltd. deal

Roche received exclusive worldwide marketing rights, excluding Japan, from Kyowa Hakko to an adenosine A2 receptor antagonist to treat Parkinson's disease. The companies will jointly develop the comp...